The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

President Donald Trump said Monday that the White House is “very strongly” considering signing an executive order to ...

Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

The FDA has proposed adding bemotrizinol, a new sunscreen ingredient, to the U.S. approval list, which could expand consumer ...

Ventura Foods salad dressing recall affects thousands of cases at major retailers such as Costco due to black plastic ...

The firings come one month after the company voluntarily pulled a drug from the market at the request of the Food and Drug ...

Pfizer Inc., AstraZeneca Plc and other companies have struck deals with the Trump administration in recent months ...

The move wouldn't legalize marijuana, but moving it from Schedule I to Schedule III would allow the FDA to study it for ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.